autologous stem cell therapy (Colorado Institute for Drug, Device and Diagnostic Development)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous stem cell therapy (Colorado Institute for Drug, Device and Diagnostic Development)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColorado Institute For Drug, Device & Diagnostic Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColorado Institute For Drug, Device & Diagnostic Development
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A